University research records
Zanjan University of Medical Sciences
5 imported, source-linked research records. Published in the last five years.
Published in the last five years
Back to university profile →5 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Zanjan University of Medical Sciences are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–5 of 5 matching records. Counts update as records arrive.
The effects of sodium-glucose cotransporter-2 inhibitors in chemotherapy-induced cardiotoxicity and mortality in patients with cancer: a systematic review and meta-analysis
May 27, 2025 · 3 citations · Open access
Open original record →Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats
January 10, 2025 · 8 citations · Open access
Open original record →Empagliflozin improves left ventricular ejection fraction and end systolic volume in patients with type 2 diabetes mellitus and coronary artery disease: a post-hoc analysis of EMPA-CARD trial
March 7, 2024 · 1 citations · Open access
Open original record →The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials
November 23, 2023 · 34 citations · Open access
Open original record →Empagliflozin improves high-sensitive cardiac troponin-I and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus and coronary artery disease: a post-hoc analysis of EMPA-CARD Trial
September 22, 2023 · 14 citations · Open access
Open original record →